NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

Wow still talking about that issue. When Linda summarized that Phase 3 trials are strategically well positioned:
- 6 mos only a third of P1 PFS
- P = 0.02 to achieve 6 mos meaning cushion there
- built in option to increase trial size)
She was trying to clear the air of the asbestos AF was pumping through to help the investor see clearly. What reaction do we get? IMO, a lot of talk about an issue that doesn't exist. A possibility yes, legitimate conversation and we just had it. However until it is verified or authenticated to the level of a real issue, imho, it is only speculation to the level of "why did she mention that, must be something there, let's extrapolate from that?", especially when Linda explicitly said they had no plans of this.

On why the stock price is down, the steady deliberate investors can't buy more, the manipulated investors ended up sold, general market decline, and someone with the initials AF is smiling in a corner somewhere. My hope was to have more conversation on the growth side of the equation, now that we have projected revenues from Germany coming in. To me that's real and it's relevant to the market cap. Pyr was the only talking about label extension, as I recall. That is huge. How about country extension, or label extension as part of hospital exemption?